Frovatriptan Succinate Tablet shortage
Frovatriptan Succinate Tablet is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 22, 2026.
Endo Pharmaceuticals is permanently stopping production of frovatriptan succinate 2.5 mg tablets. Other makers have not reported a shortage, so the same medicine may still be available from other sources.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Frovatriptan Succinate Tablet. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Feb 24, 2026Currently in shortage2 of 2 products affected.
-
Feb 24, 2026More presentations reported1 more product added to the shortage.
-
Nov 12, 2025First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Endo Pharmaceuticals, Inc. 📞 800-828-9393 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Frova, Tablet, 2.5 mg (NDC 63481-025-09) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Frova, Tablet, 2.5 mg (NDC 0603-3718-34) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
These rows are manufacturer reports to the FDA for Frovatriptan Succinate Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Frovatriptan Succinate Tablet? options further down this page.
Why is Frovatriptan Succinate Tablet in shortage?
Endo Pharmaceuticals has made a business decision to permanently stop making Frova (frovatriptan succinate) 2.5 mg tablets. Both package sizes they carried — NDC 0603-3718-34 and NDC 63481-025-09 — are being discontinued. The FDA didn't receive a specific public explanation beyond it being a business decision on Endo's part, so unfortunately there's no more detail to share about the reasoning behind it.
It's worth knowing that this report only covers Endo Pharmaceuticals and their specific products. It does not mean frovatriptan is going away from every manufacturer — other companies may still produce it, and those would be listed separately.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Frovatriptan Succinate Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Frovatriptan Succinate Tablet?
Frovatriptan succinate 2.5 mg tablets are currently on the FDA drug-shortage list, so I want to walk you through what this means for you.
The affected strength is the 2.5 mg tablet, which is the only strength involved here. At this time, the manufacturer that filed this report—Endo Pharmaceuticals, maker of the brand Frova—has no available supply of the 2.5 mg tablet. This is not because of a production problem; the reported reason is a business decision to discontinue making the drug. Because this is a discontinuation, this particular supply may not come back.
The important point is that other companies still make frovatriptan 2.5 mg tablets, so the medicine itself is not gone from the market.
Here is what I suggest:
- Do not stop, skip, or change your dose on your own. Keep taking your medicine as prescribed.
- Ask your pharmacy whether they can source frovatriptan 2.5 mg from another maker—the same medicine is available from Ingenus, Glenmark, and Amneal. It may not be in local stock, but your pharmacy can check.
- If it cannot be found, talk with your prescriber or pharmacist about a suitable option.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This reflects national data and may not match your local pharmacy's stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Frovatriptan Succinate Tablet?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Frovatriptan Succinate Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Frovatriptan | FROVATRIPTAN SUCCINATE 2.5 mg/1 | Tablet, Film Coated · Oral | Ingenus Pharmaceuticals, LLC | 50742-0299-09 |
| Frovatriptan Succinate | FROVATRIPTAN SUCCINATE 2.5 mg/1 | Tablet, Film Coated · Oral | Glenmark Pharmaceuticals Inc., USA | 68462-0694-97 |
| Frovatriptan | FROVATRIPTAN SUCCINATE 2.5 mg/1 | Tablet, Film Coated · Oral | Amneal Pharmaceuticals NY LLC | 69238-1539-09 |
Therapeutic equivalents & pricing 5 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Frovatriptan 2.5 mg | Ingenus | 9 tablets | $2.781 | AB | Availability likely |
| frovatriptan succinate 2.5 mg | Glenmark | 9 tablets | $2.781 | AB | Availability likely |
| Frovatriptan 2.5 mg | Amneal | 9 tablets | $2.781 | AB | Availability likely |
| Frovatriptan Succinate 2.5 mg | Par | 9 tablets | $3.251 | — | Discontinued |
| Frova 2.5 mg | Endo | 9 tablets | $136.033 | — | Discontinued |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Frovatriptan Succinate Tablet — that fall in the same broad treatment class (antimigraine preparations) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other neurology shortages
Frovatriptan Succinate Tablet shortage FAQs
Is Frovatriptan Succinate Tablet in shortage?
Which products are affected?
When will Frovatriptan Succinate Tablet be available again?
Can I still get Frovatriptan Succinate somewhere?
What should I do if I take Frovatriptan Succinate Tablet?
Still have a question about the Frovatriptan Succinate Tablet shortage?
Ask a pharmacist about this shortage →View Frovatriptan Succinate Tablet on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.